Abstract
To the Editor, Walker and coauthors [5] recently reported on the effects of introducing a new clinical care pathway in the management of bronchiolitis in infants aged below 6 months. They observed a significant reduction in the use of salbutamol and ipratropium bromide, and an overall reduction in the duration of hospital stay while the prescription rate of antibiotics
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
